Artelo Biosciences earnings were -$9.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ARTL earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$2.4M, down 37.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ARTL reported annual earnings of -$9.8M, with 5.8% growth.
What were Artelo Biosciences's earnings last quarter?
On ARTL's earnings call on Invalid Date, Artelo Biosciences (NASDAQ: ARTL) reported Q1 2025 earnings per share (EPS) of -$4.32, up 7.69% year over year. Total ARTL earnings for the quarter were -$2.37 million. In the same quarter last year, Artelo Biosciences's earnings per share (EPS) was -$4.68.
As of the last Artelo Biosciences earnings report, Artelo Biosciences is currently losing money. Artelo Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$9.72 million, a 1.16% increase year over year.
What was ARTL's earnings growth in the past year?
As of Artelo Biosciences's earnings date in Invalid Date, Artelo Biosciences's earnings has grown year over year. ARTL earnings in the past year totalled -$9.72 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.